Business Wire

Q4 and Full FY22 Results: Mytheresa Accelerates Growth in Q4 and Concludes the Full Fiscal Year With a GMV Growth of 21.3%, a Two-Year GMV Growth of 66.3% and a Record Profitability of 9.6% Adjusted EBITDA Margin

Share

MYT Netherlands Parent B.V. (NYSE: MYTE) (“Mytheresa” or the “Company”), the parent company of Mytheresa Group GmbH, today announced financial results for its fourth quarter and full fiscal year 2022 ended June 30, 2022. The luxury multi-brand digital platform delivered strong results for the full fiscal year and another quarter of continued top-line growth with increased profitability. Mytheresa sees itself perfectly positioned to take advantage of the ongoing shift to online of luxury consumers, the continued consolidation in the digital luxury sector and the global market share expansion opportunities.

Michael Kliger, Chief Executive Officer of Mytheresa, said, “Our strong financial results for fiscal year 2022, as well as for the fourth quarter, put us at the very top of performance of digital platforms. The results prove the unique positioning and business model of Mytheresa. We showed strong growth and profitability against a backdrop of economic and geopolitical challenges. We remain very confident that the high-end digital luxury sector combined with our superior business model will provide excellent results for our investors in the years to come. We will, of course, remain very agile in reacting to external developments and their potential impact on our business.”

Kliger continued, “In the fourth quarter, our GMV growth accelerated from Q3, we saw above average GMV growth in the United States, where we strengthened our position as a top of mind shopping destination for luxury consumers. Customer engagement and retention continued to increase, which speaks to our unique positioning attracting a highly valuable multi-brand customer that appreciates our excellent service. We see ourselves as one of the few winners in the clearly consolidating luxury ecommerce space.”

FINANCIAL HIGHLIGHTS FOR THE FOURTH QUARTER ENDED JUNE 30, 2022

  • GMV growth of 18.2% year-over-year to €196.7 million, compared to €166.4 million in the prior year period
  • Net sales increase of €12.5 million, or 7.7% year-over-year to €174.8 million slower than GMV due to planned transition of brands to the Curated Platform Model (CPM) and the subsequent effect of recording the platform fee as Net Sales
  • Gross Profit growth of 22.4%. Increase of 650 basis points in gross profit margin to 54.2% compared to 47.7% in the prior year period, driven by an increase in sales from CPM generating 100% gross margin
  • Adjusted EBITDA growth of 22.7% to €13.8 million and increase in adjusted EBITDA margin of 100 basis points to 7.9% compared to the previous quarter
  • Adjusted operating income margin of 6.5%, compared to 5.6% in the prior year period
  • Adjusted net income margin of 6.7%, compared to 4.7% in the prior year period

FINANCIAL HIGHLIGHTS FOR THE TWELVE MONTHS ENDED JUNE 30, 2022

  • GMV growth of 21.3% to €747.3 million, compared to €616.1 million in fiscal year 2021
  • Net sales increase to €689.8 million, a 12.7% growth from €612.1 in fiscal year 2021
  • Gross Profit growth of 23.7%. Increase of 460 basis points in gross profit margin to 51.5% compared to 46.9% in the prior year, driven by an increase in sales from CPM generating 100% gross margin
  • Adjusted EBITDA growth of 20.7% to €66.3 million and increase in adjusted EBITDA margin of 60 basis points to 9.6% compared to the previous fiscal year
  • Adjusted operating income margin of 8.3%, compared to 7.6% in the previous full fiscal year
  • Increase of 130 basis points in the adjusted net income margin to 6.5% for the full fiscal year 2022
  • Net increase in cash and cash equivalents in the twelve-month period of €36.8 million

RECENT BUSINESS HIGHLIGHTS

Strong Global Expansion:

  • Accelerated global GMV growth with +18.2% vs. Q4 FY21 and strong full FY22 growth with +21.3% vs. FY21 as well as +66.3% vs. full FY20
  • Above average GMV growth again in the United States with +28.0% vs. Q4 FY21
  • Record number of high-impact top customer events held across Europe and the United States
  • Successful launch of new LIFE category with home décor and other lifestyle products opening up future growth potential

Continued Brand Partnerships:

  • Launch of record number of exclusive capsule collections and pre-launches in collaboration with Dolce & Gabbana, Dries van Noten, Pucci, Bottega Veneta, Gucci, Zimmermann, Valentino and many more
  • Digital pop up with Rimowa presenting the “Originals” as well as global premiere of the new color animation “Quartz”
  • Continued roll-out with strong financials of the Curated Platform Model (CPM) with 6 brands live

High-quality Customer Growth:

  • LTM growth of active customers of 16.4% reaching 781,000 customers
  • Solid number of first-time buyers in Q4 FY22 with over 120,000 customers
  • Repurchase rates of new customer cohorts acquired in Q2 FY22 show positive trend vs. Q2 FY21 cohort in Q4
  • Strong growth of number of top customers with 22.1% in Q4 FY22 vs. Q4 FY21 as well as an increase in average GMV per all customers of 5.8% in Q4 FY22 vs. Q4 FY21

Consistent Strong Operational Performance:

  • Strong operational customer benefits with the expected completion in FY24 of the new warehouse at Leipzig Airport, currently progressing according to plan
  • Maintained very high customer satisfaction with an industry-leading Net Promoter Score of 83.2% in Q4 FY22
  • Achieved strong Gross Profit Margin with 54.2% in Q4 FY22 based on continued focus on full-price business and increasing share of CPM generating 100% gross profit
  • All operational indicators showed in FY22 an excellent level of resilience and adaptability of the Mytheresa business model despite challenging business conditions

BUSINESS OUTLOOK

For the full fiscal year ending June 30, 2023, we expect:

  • GMV in the range of €865 million to €910 million, representing a 16% to 22% growth
  • Net Sales of €755 million to €800 million, representing 10% to 16% growth
  • Gross profit at €410 million to €435 million, representing a 16% to 22% growth
  • Adjusted EBITDA in the range of €68 million to €76 million and an Adjusted EBITDA margin of 9.0% to 9.5%

For the medium-term we confirm our targets of annual GMV Growth of 22% to 25% as well as a slightly increasing Adjusted EBITDA margin around 9% to 10%.

The foregoing forward-looking statements reflect Mytheresa’s expectations as of today's date. Given the number of risk factors, uncertainties and assumptions discussed below, actual results may differ materially. Mytheresa does not intend to update its forward-looking statements until its next quarterly results announcement, other than in publicly available statements.

CONFERENCE CALL AND WEBCAST INFORMATION

Mytheresa will host a conference call to discuss its fourth quarter and full fiscal year 2022 financial results on September 15, 2022 at 8:00am Eastern Time. Those wishing to participate via webcast should access the call through Mytheresa’s Investor Relations website at https://investors.mytheresa.com. Those wishing to participate via the telephone may dial in at +1 (844) 200-6205 (USA) or +1 (929) 526-1599 (International). The passcode will be 702246. A replay will be available via webcast through Mytheresa’s Investor Relations website. The telephone replay will be available from 11:00am Eastern Time on September 16, 2022, through September 22, 2022, by dialing +1 (866) 813-9403 (USA) or +44 204 525-0658 (International). The replay passcode will be 829670.

FORWARD LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to the impact of the COVID-19 global pandemic; the impact of restrictions on use of identifiers for advertisers (IDFA); future sales, expenses, and profitability; future development and expected growth of our business and industry; our ability to execute our business model and our business strategy; having available sufficient cash and borrowing capacity to meet working capital, debt service and capital expenditure requirements for the next twelve months; and projected capital spending. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are only predictions. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects, you should carefully consider the factors set forth below.

We undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make.

You should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent our management’s beliefs and assumptions only as of the date such statements are made.

Further information on these and other factors that could affect our financial results is included in filings we make with the U.S. Securities and Exchange Commission (“SEC”) from time to time, including the section titled “Risk Factors” included in the form 20-F filed on October 15, 2021 under Rule 424(b)(4) of the Securities Act. These documents are available on the SEC’s website at www.sec.gov and on the SEC Filings section of the Investor Relations section of our website at: https://investors.mytheresa.com.

ABOUT NON-IFRS FINANCIAL MEASURES AND OPERATING METRICS

We review a number of operating and financial metrics, including the following business and non-IFRS metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions. We present Adjusted EBITDA, Adjusted Operating Income, Adjusted Net Income and Adjusted EBITDA Margin as well as Adjusted Operating Income Margin and Adjusted Net Income Margin because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance. Adjusted EBITDA, Adjusted Operating Income, and Adjusted Net Income have limitations, because they exclude certain types of expenses. We use Adjusted EBITDA, Adjusted Operating Income, Adjusted Net Income as well as Adjusted EBITDA Margin, Adjusted Operating Income Margin and Adjusted Net Income Margin as supplemental information only. You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis.

Our non-IFRS financial measures include:

  • Adjusted EBITDA is a non-IFRS financial measure that we calculate as net income before finance expense (net), taxes, and depreciation and amortization, adjusted to exclude IPO preparation and transaction costs, Other transaction-related, certain legal and other expenses and IPO-related share-based compensation expenses. Adjusted EBITDA Margin is a non-IFRS measure which is calculated in relation to net sales.
  • Adjusted Operating Income is a non-IFRS financial measure that we calculate as operating income, adjusted to exclude IPO preparation and transaction costs, Other transaction-related, certain legal and other expenses and IPO-related share-based compensation expenses. Adjusted Operating Income Margin is a non-IFRS measure which is calculated in relation to net sales.
  • Adjusted Net Income is a non-IFRS financial measure that we calculate as net income, adjusted to exclude finance expenses on our Shareholder Loans, IPO preparation and transaction costs, Other transaction-related, certain legal and other expenses, IPO-related share-based compensation expenses and related income tax effects. Adjusted Net Income Margin is a non-IFRS measure which is calculated in relation to net sales.

We are not able to forecast net income (loss) on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect net income (loss), including, but not limited to, Income taxes and Interest expense and, as a result, are unable to provide a reconciliation to forecasted Adjusted EBITDA.

Gross Merchandise Value (GMV) is an operative measure and means the total Euro value of orders processed. GMV is inclusive of merchandise value, shipping and duty. It is net of returns, value added taxes, applicable sales taxes and cancellations. GMV does not represent revenue earned by us. We use GMV as an indicator for the usage of our platform that is not influenced by the mix of direct sales and commission sales. The indicators we use to monitor usage of our platform include, among others, active customers, total orders shipped and GMV.

ABOUT MYTHERESA

Mytheresa is one of the leading global luxury fashion e-commerce platforms shipping to over 130 countries. Founded as a boutique in 1987, Mytheresa launched online in 2006 and offers ready-to-wear, shoes, bags and accessories for womenswear, menswear and kidswear. In 2022, Mytheresa expanded its luxury offering to home décor and lifestyle products with the launch of the category “LIFE”. The highly curated edit of over 200 brands focuses on true luxury brands such as Bottega Veneta, Burberry, Dolce&Gabbana, Gucci, Loewe, Loro Piana, Moncler, Prada, Saint Laurent, Valentino, and many more. Mytheresa’s unique digital experience is based on a sharp focus on high-end luxury shoppers, exclusive product and content offerings, leading technology and analytical platforms as well as high quality service operations. The NYSE listed company reported €612.1 million net sales (+36.2% vs. FY20) in its first fiscal year as a public company (https://investors.mytheresa.com).

Source: MYT Netherlands Parent B.V.

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics
(Amounts in € millions)

Three Months Ended

Twelve Months Ended

June 30, 2021

June 30, 2022

Change
in % / BPs

June 30, 2021

June 30, 2022

Change
in % / BPs

(in millions)

Gross Merchandise Value (GMV)(1)

€ 166.4

€ 196.7

18.2%

€ 616.1

€ 747.3

21.3%

Active customer (LTM in thousands)(1,2)

671

781

16.4%

671

781

16.4%

Total orders shipped (LTM in thousands)(1,2)

1,505

1,765

17.2%

1,505

1,765

17.2%

Net sales

€ 162.4

€ 174.8

7.7%

€ 612.1

€ 689.8

12.7%

Gross profit

€ 77.4

€ 94.8

22.4%

€ 287.0

€ 355.0

23.7%

Gross profit margin(3)

47.7%

54.2%

650 BPs

46.9%

51.5%

460 BPs

Adjusted EBITDA(4)

€ 11.2

€ 13.8

22.7%

€ 54.9

€ 66.3

20.7%

Adjusted EBITDA margin(3,4)

6.9%

7.9%

100 BPs

9.0%

9.6%

60 BPs

Adjusted Operating Income(4)

€ 9.1

€ 11.4

25.4%

€ 46.7

€ 57.2

22.6%

Adjusted Operating Income margin(3,4)

5.6%

6.5%

90 BPs

7.6%

8.3%

70 BPs

Adjusted Net Income(4)

€ 7.6

€ 11.8

55.1%

€ 32.1

€ 44.5

38.6%

Adjusted Net Income margin(3,4)

4.7%

6.7%

200 BPs

5.2%

6.5%

130 BPs

(1) Definition of GMV, Active customer and Total orders shipped can be found on page 62 in our Annual Report.
(2) Active customers and total orders shipped are calculated based on orders shipped from our sites during the last twelve months (LTM) ended on the last day of the period presented.
(3) As a percentage of net sales.
(4) Adjusted EBITDA, Adjusted Operating Income, Adjusted Net Income and Adjusted EBITDA Margin, Adjusted Operating Margin and Adjusted Net Income Margin are measures not defined under IFRS. For further information about how we calculate these measures and limitations of its use, see the following pages.

MYT Netherlands Parent B.V.

Financial Results and Key Operating Metrics
(Amounts in € millions)

The following tables set forth the reconciliations of net income to EBITDA and adjusted EBITDA, operating income to adjusted operating income and net income to adjusted net income:

Three Months Ended

Twelve Months Ended

June 30, 2021

June 30, 2022

Change
in %

June 30, 2021

June 30, 2022

Change
in %

(in millions)

Net income

€ (8.0)

€ 1.6

(120.6%)

€ (32.6)

€ (7.9)

(75.8%)

Finance expenses, net

€ (0.3)

€ 0.3

(191.5%)

€ (15.1)

€ 1.0

(106.6%)

Income tax expense

€ 2.1

€ (0.7)

(133.0%)

€ 15.5

€ 11.7

(24.5%)

Depreciation and amortization

€ 2.1

€ 2.4

11.0%

€ 8.2

€ 9.1

10.4%

thereof depreciation of right-of use assets

€ 1.3

€ 1.5

14.5%

€ 5.2

€ 5.7

8.3%

EBITDA

€ (4.1)

€ 3.6

(188.0%)

€ (23.9)

€ 13.9

(158.2%)

IPO preparation and transaction

costs(1)

€ 0.0

€ 0.0

N/A

€ 7.0

€ 0.0

(100.0%)

Other transaction-related, certain

legal and other expenses(2)

€ 0.0

€ 1.2

N/A

€ 0.0

€ 2.5

N/A

IPO related share-based

compensation

€ 15.3

€ 9.0

(41.4%)

€ 71.9

€ 49.9

(30.6%)

Adjusted EBITDA

€ 11.2

€ 13.8

22.7%

€ 54.9

€ 66.3

20.7%

Reconciliation to Adjusted EBITDA Margin

Net Sales

€ 162.4

€ 174.8

7.7%

€ 612.1

€ 689.8

12.7%

Adjusted EBITDA Margin

6.9%

7.9%

100 BPs

9.0%

9.6%

60 BPs

Three Months Ended

Twelve Months Ended

June 30, 2021

June 30, 2022

Change
in %

June 30, 2021

June 30, 2022

Change
in %

(in millions)

Operating Income

€ (6.2)

€ 1.3

(120.2%)

€ (32.2)

€ 4.8

(115.0%)

IPO preparation and transaction

costs(1)

€ 0.0

€ 0.0

N/A

€ 7.0

€ 0.0

(100.0%)

Other transaction-related,

certain legal and other expenses(2)

€ 0.0

€ 1.2

N/A

€ 0.0

€ 2.5

N/A

IPO related share-based

compensation)

€ 15.3

€ 9.0

(41.4%)

€ 71.9

€ 49.9

(30.6%)

Adjusted Operating Income

€ 9.1

€ 11.4

25.4%

€ 46.7

€ 57.2

22.6%

Reconciliation to Adjusted Operating Income Margin

Net Sales

€ 162.4

€ 174.8

7.7%

€ 612.1

€ 689.8

12.7%

Adjusted Operating Income Margin

5.6%

6.5%

90 BPs

7.6%

8.3%

70 BPs

Three Months Ended

Twelve Months Ended

June 30, 2021

June 30, 2022

Change
in %

June 30, 2021

June 30, 2022

Change
in %

(in millions)

Net Income

€ (8.0)

€ 1.6

(120.6%)

€ (32.6)

€ (7.9)

(75.8%)

IPO preparation and transaction

costs(1)

€ 0.0

€ 0.0

N/A

€ 7.0

€ 0.0

(100.0%)

Other transaction-related, certain

legal and other expenses(2)

€ 0.0

€ 1.2

N/A

€ 0.0

€ 2.5

N/A

IPO related share-based

compensation (3)

€ 15.3

€ 9.0

(41.4%)

€ 71.9

€ 49.9

(30.6%)

Finance expenses on shareholder

loans(4)

€ (0.3)

€ 0.0

(100.0%)

€ (16.2)

€ 0.0

(100.0%)

Income tax effect(5)

€ 0.5

€ 0.0

(100.0%)

€ 2.1

€ 0.0

(100.0%)

Adjusted Net Income

€ 7.6

€ 11.8

55.1%

€ 32.1

€ 44.5

38.6%

Reconciliation to Adjusted Net Income Margin

Net Sales

€ 162.4

€ 174.8

7.7%

€ 612.1

€ 689.8

12.7%

Adjusted Net Income Margin

4.7%

6.7%

200 BPs

5.2%

6.5%

130 BPs

(1) Represents non-recurring professional fees, including consulting, legal and accounting fees, related to our planned initial public offering (“IPO”), which are classified within selling, general and administrative expenses.
(2) Other transaction-related, certain legal and other expenses represents (i) professional fees, including advisory and accounting fees, related to potential transactions, (ii) certain legal expenses incurred outside the ordinary course of our business and (iii) other non-recurring expenses incurred in connection with the costs of establishing our new central warehouse in Leipzig, Germany.
(3) In fiscal 2021, with the effective IPO, certain key management personnel received a one-time granted share-based compensation, for which the share-based compensation expense will be recognized upon defined vesting schedules in the future periods, including €49.9 million for fiscal 2022. We do not consider these expenses to be indicative of our core operating performance.
(4) Our Adjusted Net Income excludes finance expenses associated with our Shareholder Loans, which we do not consider to be indicative of our core performance. We did not receive any cash proceeds under the Shareholder Loans, which originated as part of the Neiman Marcus acquisition in 2014. In January 2021, we repaid our Shareholder Loans (principal plus outstanding interest) using a portion of the net proceeds from our initial public offering.
(5) Reflects adjustments to historical income tax expense to reflect changes in taxable income for each of the periods presented due to changes in finance expenses related to the Shareholder Loans, assuming a statutory tax rate of 27.8%.

MYT Netherlands Parent B.V.

Consolidated Statements of Profit or Loss and Comprehensive Income
(Amounts in € thousands, except share and per share data)

(in € thousands)

Three Months Ended

Twelve Months Ended

June 30, 2021

June 30,
2022

June 30, 2021

June 30, 2022

Gross Merchandise Value (GMV)

166,395

196,654

616,123

747,277

Net sales

162,368

174,836

612,096

689,750

Cost of sales, exclusive of depreciation and amortization

(84,939)

(80,042)

(325,053)

(334,758)

Gross profit

77,429

94,794

287,043

354,992

Shipping and payment cost

(19,535)

(27,075)

(71,466)

(97,697)

Marketing expenses

(22,326)

(26,558)

(81,558)

(96,093)

Selling, general and administrative expenses

(39,449)

(36,820)

(157,151)

(148,172)

Depreciation and amortization

(2,125)

(2,360)

(8,232)

(9,088)

Other expense, net

(231)

(721)

(799)

892

Operating income

(6,237)

1,261

(32,162)

4,834

Finance income

459

0

22,416

0

Finance costs

(135)

(296)

(7,325)

(998)

Finance income (costs), net

324

(296)

15,091

(998)

Income (loss) before income taxes

(5,913)

965

(17,070)

3,836

Income tax (expense) income

(2,070)

683

(15,534)

(11,734)

Net income (loss)

(7,983)

1,648

(32,604)

(7,898)

Cash Flow Hedge

43

1,721

-

-

Income Taxes related to Cash Flow Hedge

20

(479)

-

-

Foreign currency translation

-

(35)

-

(74)

Other comprehensive income (loss)

63

1,207

-

(74)

Comprehensive income (loss)

(7,920)

2,855

(32,604)

(7,972)

Basic earnings per share in €

(0.09)

0.02

(0.42)

(0.09)

Weighted average ordinary shares outstanding (basic & diluted) - in millions

86.3

86.4

77.4

86.3

MYT Netherlands Parent B.V.

Consolidated Statements of Financial Position
(Amounts in € thousands)

(in € thousands)

June 30, 2021

June 30, 2022

Assets

Non-current assets

Non-current financial assets

175

294

Intangible assets and goodwill

155,611

155,223

Property and equipment, net

8,810

17,691

Right-of-use assets

14,009

21,677

Deferred tax assets

-

6,090

Total non-current assets

178,606

200,975

Current assets

Inventories

247,054

230,144

Trade and other receivables

5,030

8,276

Other assets

14,492

61,874

Cash and cash equivalents

76,760

113,507

Total current assets

343,335

413,801

Total assets

521,941

614,776

Shareholders’ equity and liabilities

Subscribed capital

1

1

Capital reserve

444,951

498,872

Accumulated Deficit

(60,837)

(68,734)

Other comprehensive income

1,602

1,528

Total shareholders’ equity

385,718

431,667

Non-current liabilities

Provisions

717

758

Lease liabilities

8,786

16,817

Deferred tax liabilities

2,308

3,661

Total non-current liabilities

11,811

21,237

Current liabilities

Tax liabilities

14,293

25,892

Lease liabilities

5,361

5,189

Contract liabilities

10,975

10,746

Trade and other payables

43,558

45,156

Other liabilities

50,225

74,889

Total current liabilities

124,412

161,872

Total liabilities

136,223

183,109

Total shareholders’ equity and liabilities

521,941

614,776

MYT Netherlands Parent B.V.

Consolidated Statements of Changes in Equity
(Amounts in € thousands)

(in € thousands)

Subscribed capital

Capital reserve

Accumulated deficit

Foreign currency translation reserve

Total shareholders’ equity

Balance as of July 1, 2020

1

91,008

(28,234)

1,602

64,377

Net loss

-

-

(32,604)

-

(32,604)

Other comprehensive income

-

-

-

-

-

Comprehensive loss

-

-

(32,604)

-

(32,604)

Capital increase - initial public offering

-

283,224

-

-

283,224

IPO related transaction costs

-

(4,550)

-

-

(4,550)

Share-based compensation

-

75,270

-

-

75,270

Balance as of June 30, 2021

1

444,951

(60,837)

1,602

385,718

Balance as of July 1, 2021

1

444,951

(60,837)

1,602

385,718

Net loss

-

-

(7,898)

-

(7,898)

Other comprehensive income

-

-

-

(74)

(74)

Comprehensive loss

-

-

(7,898)

(74)

(7,972)

IPO related transaction costs

-

1,249

-

-

1,249

Share options exercised

-

369

-

-

369

Share-based compensation

-

52,303

-

-

52,303

Balance as of June 30, 2022

1

498,872

(68,734)

1,528

431,667

MYT Netherlands Parent B.V.

Consolidated Statements of Cash Flows
(Amounts in € thousands)

Year ended June 30,

(in € thousands)

2021

2022

Net income (loss)

(32,604)

(7,898)

Adjustments for

Depreciation and amortization

8,232

9,088

Finance (income) costs, net

(15,091)

998

Share-based compensation

75,270

52,303

Income tax expense

15,534

11,734

Change in operating assets and liabilities

(Decrease) increase in provisions

135

41

(Increase) decrease in inventories

(77,922)

16,910

(Increase) decrease in trade and other receivables

(215)

(3,246)

Decrease (increase) in other assets

4,281

(47,382)

(Decrease) increase in other liabilities

(1,809)

24,665

Increase (decrease) in contract liabilities

4,217

(229)

Increase (decrease) in trade and other payables

7,400

1,598

Decrease (increase) in non-current financial assets

-

(119)

Income taxes paid

(3,915)

(3,623)

Net cash provided by (used in) operating activities

(16,486)

54,840

Expenditure for property and equipment and intangible assets

(2,934)

(11,923)

Proceeds from sale of property and equipment

40

-

Net cash (used in) investing activities

(2,894)

(11,923)

Interest paid

(4,257)

(998)

Proceeds from bank liabilities

64,990

-

Repayment of liabilities from banks

(74,990)

-

Repayment of Shareholder loan

(171,827)

-

Proceeds from capital increase - initial public offering

283,224

-

IPO preparation and transaction costs

(4,550)

-

Proceeds from exercise of option awards

-

369

Lease payments

(5,800)

(5,466)

Net cash (used in) provided by financing activities

86,790

(6,095)

Net increase (decrease) in cash and cash equivalents

67,411

36,822

Cash and cash equivalents at the beginning of the period

9,367

76,760

Effects of exchange rate changes on cash and cash equivalents

(18)

(74)

Cash and cash equivalents at end of the period

76,760

113,507

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor Relations Contacts
Mytheresa.com GmbH
Stefanie Muenz
phone: +49 89 127695-1919
email: investors@mytheresa.com

Solebury Strategic Communications
Deena Friedman / Maria Lycouris
phone: +1 800 929 7167
email: investors@mytheresa.com

Media Contacts for public relations
Mytheresa.com GmbH
Sandra Romano
mobile: +49 152 54725178
phone: +49 89 127695-236
email: sandra.romano@mytheresa.com

Media Contacts for business press
Mytheresa.com GmbH
Alberto Fragoso
mobile: +49 152 38297355
phone: +49 89 127695-1358
email: alberto.fragoso@mytheresa.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station9.12.2022 20:04:00 CET | Press release

RevBio, Inc., announced that anexperiment to study Tetranite®, the company’s regenerative bone adhesive biomaterial, has successfully been initiated onboard the International Space Station (ISS). On Saturday, November 26, 2022, the study materials were launched to the space station on SpaceX’s 26th Commercial Resupply Services (SpaceX CRS-26) mission, sponsored by the ISS National Laboratory. This in vivo research, which will be conducted over the next two months on the ISS, will examine the biomaterial’s ability to regenerate bone when used in a microgravity environment where bone growing conditions and the ability to regenerate new bone tissue is significantly compromised. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221201005635/en/ RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station. This Experiment will Examine TETRANITE’S Ability to Regenerate Bone under the Condition of

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials9.12.2022 14:00:00 CET | Press release

Updated results from the TROPION-PanTumor01 phase 1 trial showed datopotamab deruxtecan (Dato-DXd) continued to demonstrate encouraging responses in patients with heavily pretreated metastatic triple negative breast cancer (TNBC) and disease progression following standard treatment. Results were presented today as a poster presentation (Abstract #P6-10-03) at the 2022 San Antonio Breast Cancer Symposium (#SABCS22). Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN). Approximately 15% of breast cancers are considered triple negative and are associated with higher disease recurrence and worse prognosis compared to other breast cancer subtypes.1,2 It is estimated that only 12% of patients with metastatic TNBC survive five years after diagnosis and median overall survival is between 12 to 18 months.1,3 In the TNBC cohort of TROPION-PanTumor01 (n=44)

Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases9.12.2022 14:00:00 CET | Press release

Takeda(TSE:4502/NYSE:TAK) today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology (ASH) Annual Meeting being held December 10-13, 2022 in New Orleans. Takeda’s latest research focuses on improving long-term outcomes for patients with hematologic diseases. Takeda’s presentations will include oral sessions detailing a three-year update of the Phase 3 OPTIC trial demonstrating the efficacy and safety of ICLUSIG® (ponatinib) in patients with resistant chronic-phase chronic myeloid leukemia (CP-CML), and results from a first-in-human Phase 1/2 study evaluating modakafusp alfa (TAK-573) in patients with relapsed / refractory multiple myeloma. “Our latest research is focused on investigating novel mechanisms of action, as well as optimizing approved treatments to improve long-term outcomes and more deeply understand and address unmet needs for patients across a range of hematologic diseases,” said Awny Farajallah, M.D., Head of Global Med

Tecnotree Advances to Acquire Top AIML Platform - CognitiveScale in North America to further Enhance 5G Use case Penetration9.12.2022 13:23:00 CET | Press release

Tecnotree is a market leader in 5G digital Business Support Systems (BSS), with AI/ML capabilities and multi-cloud extensibility. Tecnotree’s global footprint with over 90 Telecom customers in 70 countries around the world, supports ecosystems of over 1 billion subscribers. Tecnotree is the first Digital Platform Service provider to be Platinum Badge Certified by TM Forum for Real-world Open API standards. The company also provides B2B2X partner ecosystem and fintech services for monetization beyond connectivity across gaming, healthcare, education, and banking. Tecnotree has been recognized by Gartner for revenue management and monetization as well as for customer experience management solutions and enjoys the position of a leading stock on the Helsinki Nasdaq since 2020. CognitiveScale (CS) is United States based pioneer in the space of AI Engineering and provides solutions for scalable enterprise AI development and deployment. CognitiveScale is backed by over 100 granted AI patents

Another Sustainability Award for NTHU9.12.2022 10:00:00 CET | Press release

National Tsing Hua University (NTHU) in Taiwan has been awarded the Taiwan University Sustainability Award for the second year in a row! The Award was announced at the 15th Taiwan Corporate Sustainability Awards (TCSA) recently held by the Taiwan Institute for Sustainable Energy (TAISE). Standing out amongst the 47 participating universities, NTHU was ranked first in the comprehensive evaluation, and in the individual competitions received the University Sustainability Report Gold Award. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221209005001/en/ NTHU president W. John Kao (right) accepting the Taiwan University Sustainability Award from You Si-kun, president of the Legislative Yuan. (Photo: National Tsing Hua University) The judges cited the exemplary way in which NTHU has adopted an innovative approach to integrating classroom learning, campus activities and social service, thereby enriching students’ education and cre